YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Pfizer to produce COVID-19 drug at Kansas plant

Posted online

Pfizer Inc. entered a deal to produce Gilead Sciences Inc.’s remdesivir drug at a plant in McPherson, Kansas.

There's been a shortage of remdesivir after the Food and Drug Administration gave emergency authorization for its use as treatment for COVID-19 patients.

Financial terms of the multiyear deal were not disclosed.

Read more from the Kansas City Business Journal.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences